Hutchmed begins phase-three trials of lymphoma therapy in China
(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More
| Price | 200.00p on 27-04-2026 at 12:52:58 |
|---|---|
| Change | -1.00p -0.5% |
| Buy | 200.00p |
| Sell | 196.00p |
| Last Trade: | Sell 1,479.00 at 200.00p |
| Day's Volume: | 68,458 |
| Last Close: | 201.00p |
| Open: | 201.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 198.00p - 202.00p |
| 52wk Range: | 192.00p - 292.00p |
| Market Capitalisation: | £1.72b |
| VWAP: | 199.29693p |
| Shares in Issue: | 859.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,479 | 200.00p | Automatic Execution |
13:52:58 - 27-Apr-26 |
| Sell* | 1,552 | 200.0619p | Ordinary |
13:52:53 - 27-Apr-26 |
| Buy* | 2 | 212.00p | SI Trade |
13:33:08 - 27-Apr-26 |
| Buy* | 1 | 212.00p | SI Trade |
13:33:08 - 27-Apr-26 |
| Sell* | 404 | 200.00p | Automatic Execution |
13:33:08 - 27-Apr-26 |
| Sell* | 162 | 200.00p | Automatic Execution |
13:33:08 - 27-Apr-26 |
| Sell* | 2,638 | 201.00p | Automatic Execution |
13:33:08 - 27-Apr-26 |
| Sell* | 5,000 | 201.00p | Ordinary |
09:05:55 - 27-Apr-26 |
| Buy* | 1 | 210.00p | SI Trade |
09:02:55 - 27-Apr-26 |
| Buy* | 247 | 201.00p | Ordinary |
08:59:12 - 27-Apr-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 9:30 am | RNS | 2025 Annual Report and Notice of AGM |
| 9th Apr 2026 7:00 am | RNS-R | Data to be Presented at AACR Annual Meeting 2026 |
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |